These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

371 related articles for article (PubMed ID: 28244661)

  • 1. Who should deliver the low FODMAP diet and what educational methods are optimal: a review.
    O'Keeffe M; Lomer MC
    J Gastroenterol Hepatol; 2017 Mar; 32 Suppl 1():23-26. PubMed ID: 28244661
    [TBL] [Abstract][Full Text] [Related]  

  • 2. History of the low FODMAP diet.
    Gibson PR
    J Gastroenterol Hepatol; 2017 Mar; 32 Suppl 1():5-7. PubMed ID: 28244673
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Re-challenging FODMAPs: the low FODMAP diet phase two.
    Tuck C; Barrett J
    J Gastroenterol Hepatol; 2017 Mar; 32 Suppl 1():11-15. PubMed ID: 28244664
    [TBL] [Abstract][Full Text] [Related]  

  • 4. How to institute the low-FODMAP diet.
    Barrett JS
    J Gastroenterol Hepatol; 2017 Mar; 32 Suppl 1():8-10. PubMed ID: 28244669
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Food regulations: low FODMAP labeling and communication goals.
    Méance S; Giordano J; Chuang E; Schneider H
    J Gastroenterol Hepatol; 2017 Mar; 32 Suppl 1():62-63. PubMed ID: 28244659
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nutritional, microbiological and psychosocial implications of the low FODMAP diet.
    Staudacher HM
    J Gastroenterol Hepatol; 2017 Mar; 32 Suppl 1():16-19. PubMed ID: 28244658
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fermentable oligosaccharides, disaccharides, monosaccharides and polyols: role in irritable bowel syndrome.
    Tuck CJ; Muir JG; Barrett JS; Gibson PR
    Expert Rev Gastroenterol Hepatol; 2014 Sep; 8(7):819-34. PubMed ID: 24830318
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The evidence base for efficacy of the low FODMAP diet in irritable bowel syndrome: is it ready for prime time as a first-line therapy?
    Gibson PR
    J Gastroenterol Hepatol; 2017 Mar; 32 Suppl 1():32-35. PubMed ID: 28244668
    [TBL] [Abstract][Full Text] [Related]  

  • 9. All that a physician should know about FODMAPs.
    Mehtab W; Agarwal A; Singh N; Malhotra A; Makharia GK
    Indian J Gastroenterol; 2019 Oct; 38(5):378-390. PubMed ID: 31802437
    [TBL] [Abstract][Full Text] [Related]  

  • 10. When the low FODMAP diet does not work.
    Halmos EP
    J Gastroenterol Hepatol; 2017 Mar; 32 Suppl 1():69-72. PubMed ID: 28244666
    [TBL] [Abstract][Full Text] [Related]  

  • 11. FODMAPs: food composition, defining cutoff values and international application.
    Varney J; Barrett J; Scarlata K; Catsos P; Gibson PR; Muir JG
    J Gastroenterol Hepatol; 2017 Mar; 32 Suppl 1():53-61. PubMed ID: 28244665
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adapting the low FODMAP diet to special populations: infants and children.
    Iacovou M
    J Gastroenterol Hepatol; 2017 Mar; 32 Suppl 1():43-45. PubMed ID: 28244674
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low fermentable oligo-di-mono-saccharides and polyols diet versus general dietary advice in patients with diarrhea-predominant irritable bowel syndrome: A randomized controlled trial.
    Zahedi MJ; Behrouz V; Azimi M
    J Gastroenterol Hepatol; 2018 Jun; 33(6):1192-1199. PubMed ID: 29159993
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of symptom response following advice for a diet low in fermentable carbohydrates (FODMAPs) versus standard dietary advice in patients with irritable bowel syndrome.
    Staudacher HM; Whelan K; Irving PM; Lomer MC
    J Hum Nutr Diet; 2011 Oct; 24(5):487-95. PubMed ID: 21615553
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dietary practices and FODMAPs in South Asia: Applicability of the low FODMAP diet to patients with irritable bowel syndrome.
    Hewawasam SP; Iacovou M; Muir JG; Gibson PR
    J Gastroenterol Hepatol; 2018 Feb; 33(2):365-374. PubMed ID: 28700090
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and Findings of a Blinded Randomized Reintroduction Phase for the Low FODMAP Diet in Irritable Bowel Syndrome.
    Van den Houte K; Colomier E; Routhiaux K; Mariën Z; Schol J; Van den Bergh J; Vanderstappen J; Pauwels N; Joos A; Arts J; Caenepeel P; De Clerck F; Matthys C; Meulemans A; Jones M; Vanuytsel T; Carbone F; Tack J
    Gastroenterology; 2024 Jul; 167(2):333-342. PubMed ID: 38401741
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Systematic review: quality of trials on the symptomatic effects of the low FODMAP diet for irritable bowel syndrome.
    Krogsgaard LR; Lyngesen M; Bytzer P
    Aliment Pharmacol Ther; 2017 Jun; 45(12):1506-1513. PubMed ID: 28440580
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Low FODMAP Diet: Many Question Marks for a Catchy Acronym.
    Catassi G; Lionetti E; Gatti S; Catassi C
    Nutrients; 2017 Mar; 9(3):. PubMed ID: 28300773
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical effectiveness and economic costs of group versus one-to-one education for short-chain fermentable carbohydrate restriction (low FODMAP diet) in the management of irritable bowel syndrome.
    Whigham L; Joyce T; Harper G; Irving PM; Staudacher HM; Whelan K; Lomer MC
    J Hum Nutr Diet; 2015 Dec; 28(6):687-96. PubMed ID: 25871564
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dietary Fermentable Oligosaccharides, Disaccharides, Monosaccharides, and Polyols (FODMAPs) and Gastrointestinal Disease.
    Vakil N
    Nutr Clin Pract; 2018 Aug; 33(4):468-475. PubMed ID: 29870082
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.